Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 2045153

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 2045153

Imaging Diagnostics Market - Strategic Insights and Forecasts (2026-2031)

PUBLISHED:
PAGES: 154 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3950
PDF & Excel (Multi User License - Up to 5 Users)
USD 4550
PDF & Excel (Enterprise License)
USD 6950

Add to Cart

The Imaging Diagnostics Market is set to reach USD 68.7 billion in 2031, growing at a CAGR of 3.8 % from USD 57.1 billion in 2026.

The global imaging diagnostics market is experiencing substantial expansion as healthcare systems increasingly adopt advanced imaging technologies for disease diagnosis, treatment planning, monitoring, and preventive healthcare. Imaging diagnostics refers to the use of medical imaging modalities such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, nuclear imaging, mammography, and molecular imaging to visualize internal body structures and identify abnormalities. These technologies play a critical role in modern healthcare by enabling accurate diagnosis, minimally invasive evaluation, and improved clinical decision-making across multiple therapeutic areas.

The increasing global burden of chronic diseases remains one of the major factors driving market growth. Rising incidences of cardiovascular diseases, cancer, neurological disorders, respiratory conditions, orthopedic disorders, and gastrointestinal diseases are increasing demand for advanced diagnostic imaging procedures. Healthcare providers are increasingly emphasizing early diagnosis and preventive healthcare approaches to improve treatment outcomes and reduce long-term healthcare costs. Imaging diagnostics technologies enable clinicians to identify diseases at earlier stages, monitor disease progression, and evaluate treatment effectiveness more accurately.

The growing aging population is significantly contributing to market expansion. Elderly populations are more susceptible to chronic illnesses, degenerative disorders, and age-related conditions requiring frequent imaging examinations and long-term disease monitoring. Increasing life expectancy and expanding geriatric patient populations are therefore creating sustained demand for imaging diagnostics services and equipment worldwide.

Technological advancements in medical imaging systems, artificial intelligence, machine learning, cloud computing, and digital healthcare platforms are transforming the imaging diagnostics landscape. Modern imaging systems provide improved image resolution, faster scanning times, enhanced automation, and reduced radiation exposure. Artificial intelligence and AI-assisted imaging analysis are increasingly utilized to improve diagnostic accuracy, workflow efficiency, and radiology reporting processes.

AI-driven imaging solutions are enabling automated image interpretation, lesion detection, predictive analytics, and clinical decision support across radiology workflows. Integration of cloud-based imaging platforms and picture archiving and communication systems (PACS) is also improving healthcare interoperability and remote diagnostics capabilities.

The market is also benefiting from increasing healthcare expenditure and expansion of diagnostic infrastructure across developed and emerging economies. Governments and private healthcare organizations are investing significantly in hospital modernization, digital radiology systems, and advanced imaging technologies to strengthen healthcare delivery capabilities. Expanding access to healthcare services and diagnostic imaging facilities is expected to support long-term market growth.

Growing demand for minimally invasive diagnostics and image-guided procedures is further influencing market expansion. Imaging technologies are increasingly utilized in interventional radiology, surgical planning, oncology treatment monitoring, and precision medicine applications. Hybrid imaging modalities such as PET/CT and PET/MRI are also gaining adoption due to their ability to provide both anatomical and functional imaging information.

North America currently dominates the imaging diagnostics market due to advanced healthcare infrastructure, high healthcare expenditure, strong adoption of digital imaging technologies, and significant investment in radiology innovation. Europe also represents a major market supported by increasing chronic disease burden and expansion of diagnostic imaging services. Asia Pacific is expected to witness rapid growth due to rising healthcare expenditure, improving healthcare infrastructure, and growing awareness regarding early disease diagnosis in countries such as China, India, Japan, and South Korea.

Despite strong growth prospects, the market faces challenges related to high equipment costs, radiation safety concerns, shortage of skilled radiologists, and reimbursement limitations. However, ongoing advancements in artificial intelligence, molecular imaging, portable imaging systems, and digital healthcare integration are expected to create substantial long-term growth opportunities for the imaging diagnostics market.

Market Drivers

Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases such as cancer, cardiovascular disorders, neurological diseases, respiratory illnesses, and musculoskeletal conditions is one of the primary drivers of the imaging diagnostics market.

Healthcare providers increasingly rely on imaging technologies for disease detection, staging, treatment planning, and monitoring. The growing emphasis on early diagnosis and preventive healthcare is significantly strengthening demand for advanced imaging systems.

Growing Aging Population

The expanding global geriatric population is contributing significantly to market growth. Elderly individuals are more susceptible to chronic diseases and age-related disorders that require frequent diagnostic imaging procedures.

Increasing life expectancy and rising healthcare utilization among older adults are creating sustained demand for radiology services and imaging equipment worldwide.

Advancements in Imaging Technologies

Continuous innovation in MRI, CT, ultrasound, digital radiography, molecular imaging, and nuclear medicine technologies is positively influencing the market. Modern imaging systems provide enhanced image quality, faster processing speeds, improved patient comfort, and reduced radiation exposure.

Advanced imaging technologies are improving diagnostic precision and supporting more effective clinical decision-making across healthcare settings.

Integration of Artificial Intelligence in Radiology

Artificial intelligence and machine learning technologies are increasingly integrated into imaging diagnostics workflows to improve efficiency and diagnostic accuracy. AI-assisted image analysis supports automated lesion detection, image reconstruction, predictive analytics, and radiology reporting.

Healthcare organizations are increasingly adopting AI-enabled imaging solutions to address radiologist shortages and improve workflow productivity.

Expansion of Healthcare Infrastructure

Governments and private healthcare providers are significantly increasing investment in healthcare infrastructure and diagnostic imaging facilities. Expansion of hospitals, diagnostic centers, ambulatory care facilities, and telemedicine platforms is supporting broader access to imaging services.

Emerging economies are increasingly investing in digital healthcare transformation and modernization of radiology infrastructure.

Market Restraints

High Cost of Imaging Equipment

One of the major restraints affecting the imaging diagnostics market is the high cost associated with advanced imaging systems and infrastructure installation. MRI scanners, CT systems, PET scanners, and hybrid imaging technologies require substantial capital investment and maintenance expenses.

Smaller healthcare facilities and institutions in developing regions may face financial barriers related to adoption of advanced imaging equipment.

Radiation Exposure Concerns

Certain imaging modalities such as CT scans and X-rays involve exposure to ionizing radiation, which may raise patient safety concerns. Repeated imaging procedures may increase long-term radiation-related health risks.

Healthcare providers continue emphasizing dose optimization strategies and radiation safety protocols to minimize exposure risks.

Shortage of Skilled Radiologists and Technicians

The increasing demand for imaging services is creating pressure on healthcare systems facing shortages of trained radiologists, imaging technicians, and specialized healthcare personnel.

Lack of skilled professionals may affect diagnostic efficiency, workflow management, and interpretation accuracy in certain regions.

Reimbursement and Regulatory Challenges

Imaging diagnostics technologies are subject to strict regulatory approval requirements related to safety, efficacy, and quality standards. Reimbursement policies for diagnostic imaging procedures also vary significantly across healthcare systems and regions.

Limited reimbursement support may affect adoption of advanced imaging procedures and technologies.

Technology and Segment Insights

The imaging diagnostics market is segmented by modality, application, end-user, and geography. By modality, the market includes X-ray imaging, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, nuclear imaging, mammography, and others. X-ray imaging currently accounts for a substantial market share due to widespread clinical utilization, affordability, and high diagnostic procedure volume.

MRI and CT imaging are also major market segments due to increasing demand for high-resolution imaging in oncology, neurology, cardiology, and orthopedic applications.

Based on application, the market includes oncology, cardiology, neurology, orthopedics, gynecology, pulmonology, gastroenterology, and others. Oncology currently represents a dominant market segment because imaging diagnostics play a critical role in cancer detection, tumor staging, treatment monitoring, and precision oncology workflows.

Cardiology and neurology are also significant application areas due to increasing prevalence of cardiovascular diseases and neurological disorders.

By end-user, the market includes hospitals, diagnostic imaging centers, ambulatory surgical centers, specialty clinics, and academic and research institutions. Hospitals currently account for the largest market share due to extensive utilization of imaging systems for emergency care, inpatient diagnostics, surgical planning, and disease monitoring.

Diagnostic imaging centers are also witnessing rapid growth because of increasing demand for outpatient imaging services and specialized radiology procedures.

Regionally, North America dominates the market due to advanced healthcare infrastructure, strong radiology adoption, and high healthcare expenditure. Europe continues to witness substantial growth supported by increasing chronic disease prevalence and digital healthcare initiatives. Asia Pacific is expected to experience rapid expansion due to improving healthcare infrastructure, rising medical tourism, and increasing healthcare investment.

Competitive and Strategic Outlook

The imaging diagnostics market is highly competitive and characterized by the presence of major medical device manufacturers, imaging technology providers, and healthcare technology companies. Key market participants include GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Hitachi, Ltd., Hologic, Inc., Carestream Health, Inc., Shimadzu Corporation, and Samsung Medison Co., Ltd.

Leading companies are increasingly focusing on artificial intelligence integration, workflow automation, cloud-based imaging platforms, and advanced visualization technologies to strengthen market positioning. Investments in digital radiology, portable imaging systems, and AI-assisted diagnostics are accelerating across the industry.

GE HealthCare and Siemens Healthineers continue to maintain strong market positions through advanced MRI, CT, ultrasound, and molecular imaging portfolios. Philips and Canon Medical Systems are expanding imaging capabilities through AI-enabled radiology solutions and integrated healthcare informatics platforms.

Medical imaging companies are increasingly investing in portable and point-of-care imaging systems to improve accessibility and support decentralized healthcare delivery. Strategic collaborations between healthcare providers, technology companies, and AI developers are accelerating innovation in imaging diagnostics and clinical workflow optimization.

The market is also witnessing increasing focus on reducing scan times, improving image quality, minimizing radiation exposure, and expanding remote diagnostics capabilities. Companies capable of improving operational efficiency, affordability, and diagnostic precision are expected to strengthen long-term market competitiveness.

Conclusion

The global imaging diagnostics market is expected to witness strong growth due to increasing prevalence of chronic diseases, rising demand for early disease detection, and continuous advancements in medical imaging technologies.

Imaging diagnostics technologies are transforming healthcare by enabling accurate diagnosis, minimally invasive evaluation, and personalized treatment planning across multiple therapeutic areas. Growing investment in digital healthcare, artificial intelligence, and advanced imaging infrastructure is further strengthening market expansion.

Technological advancements in MRI, CT, ultrasound, molecular imaging, and AI-driven radiology are significantly improving diagnostic precision, workflow efficiency, and patient outcomes. However, challenges related to high equipment costs, radiation exposure concerns, shortage of skilled professionals, and reimbursement limitations continue to affect broader market adoption.

Despite these restraints, ongoing innovation in artificial intelligence, portable imaging systems, cloud-based radiology platforms, and precision diagnostics is expected to create substantial long-term growth opportunities for the imaging diagnostics market.

Key Benefits of this Report

  • Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation, and trade analysis
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments
Product Code: KSI-008601

TABLE OF CONTENTS

1. Executive Summary

  • 1.1 Market Snapshot
  • 1.2 Key Findings
  • 1.3 Analyst Insights
  • 1.4 Strategic Recommendations

2. Research Methodology

  • 2.1 Research Design
  • 2.2 Data Collection
  • 2.3 Market Size Estimation
  • 2.4 Forecasting Model
  • 2.5 Assumptions & Limitations

3. Imaging Diagnostics Market Overview, Size, and Forecast

  • 3.1 Market Introduction
  • 3.2 Market Definition & Scope
  • 3.3 Evolution of the Industry
  • 3.4 Key Trends Shaping the Market
  • 3.4 Global Market Size (Historical: 2021-2025)
  • 3.5 Forecast (2026-2031)
  • 3.6. Prevalence Data

4. Market Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Market Challenges

5. Business Landscape

  • 5.1 Industry Value Chain Analysis
  • 5.2 Pricing Analysis
  • 5.3 Reimbursement Scenario

6. Technological Landscape

  • 6.1 Emerging Technologies
  • 6.2 Pipeline Analysis
  • 6.3 AI / Digital Health Integration

7. Regulatory Framework

  • 7.1 FDA / EMA / CDSCO Guidelines
  • 7.2 Approval Processes
  • 7.3 Compliance Requirements

8. Imaging Diagnostics Market Landscape Analysis

  • 8.1 Analysis by Imaging Modality
  • 8.2 Analysis by Biomarker Type
  • 8.3 Analysis Application
  • 8.4 Analysis by End User

9. Imaging Diagnostics Market Market Segmentation (2021-2031)

  • 9.1. By Imaging Modality
    • 9.1.1. Magnetic Resonance Imaging (MRI)
    • 9.1.2. Computed Tomography (CT)
    • 9.1.3. Positron Emission Tomography (PET)
    • 9.1.4. Ultrasound
    • 9.1.5. X-ray
    • 9.1.6. Others
  • 9.2. By Biomarker Type
    • 9.2.1. Protein Biomarkers
    • 9.2.2. Genetic Biomarkers
    • 9.2.3. Metabolic Biomarkers
    • 9.2.4. Cellular Biomarkers
    • 9.2.5. Others
  • 9.3. By Application
    • 9.3.1. Oncology
    • 9.3.2. Cardiology
    • 9.3.3. Neurology
    • 9.3.4. Infectious Diseases
    • 9.3.5. Others
  • 9.4. By End-User
    • 9.4.1. Hospitals
    • 9.4.2. Diagnostic Imaging Centers
    • 9.4.3. Research Institutes
    • 9.4.4. Others

10. Geographical Analysis (2021-2031)

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 South America
  • 10.5 Middle East & Africa

11. Country Analysis (2021-2031)

  • 11.1. U.S.
  • 11.2 Germany
  • 11.3 United Kingdom
  • 11.4 China
  • 11.5 Japan
  • 11.6 India
  • 11.7 Brazil
  • 11.8 Canada
  • 11.9 France
  • 11.10 Italy
  • 11.11 Spain
  • 11.12 South Korea
  • 11.13 Mexico
  • 11.14 United Arab Emirates
  • 11.15 Saudi Arabia

12. Competitive Landscape

  • 12.1 Market Share Analysis
  • 12.2 Competitive Benchmarking
  • 12.3 Strategic Developments
  • 12.4 Mergers & Acquisitions
  • 12.5 Partnerships
  • 12.6 Product Launches

13. Company Profiles

  • 13.1. Siemens Healthineers AG
    • 13.1.1. Overview
    • 13.1.2. Financials
    • 13.1.3. Product Portfolio
    • 13.1.4. Recent Developments
  • 13.2. GE HealthCare Technologies Inc.
    • 13.2.1. Overview
    • 13.2.2. Financials
    • 13.2.3. Product Portfolio
    • 13.2.4. Recent Developments
  • 13.3. Koninklijke Philips N.V.
    • 13.3.1. Overview
    • 13.3.2. Financials
    • 13.3.3. Product Portfolio
    • 13.3.4. Recent Developments
  • 13.4. Canon Medical Systems Corporation
  • 13.5. Hitachi, Ltd.
    • 13.5.1. Overview
    • 13.5.2. Financials
    • 13.5.3. Product Portfolio
    • 13.5.4. Recent Developments
  • 13.6. Hologic, Inc.
  • 13.7. FUJIFILM Holdings Corporation
    • 13.7.1. Overview
    • 13.7.2. Financials
    • 13.7.3. Product Portfolio
    • 13.7.4. Recent Developments
  • 13.8. Agilent Technologies, Inc.
    • 13.8.1. Overview
    • 13.8.2. Financials
    • 13.8.3. Product Portfolio
    • 13.8.4. Recent Developments
  • 13.9. Bruker Corporation
    • 13.9.1. Overview
    • 13.9.2. Financials
    • 13.9.3. Product Portfolio
    • 13.9.4. Recent Developments
  • 13.10. PerkinElmer, Inc.

14. Investment & Funding Analysis

  • 14.1 Venture Capital Trends
  • 14.2 Government Funding
  • 14.3 R&D Investments

15. Future Outlook

  • 15.1 Key Growth Areas
  • 15.2 Disruptive Trends
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!